A patient and physician survey of fibromyalgia across Latin America and Europe

Table 2 Proportion of patients, PCPs, and specialists who report each symptom as “Very” or “Extremely” disruptive

	Patients (%)		PCPs (%)^a		Specialists (%)^a
Common symptoms	Latin America (N = 300)	Europe (N = 600)	Latin America (N = 253)	Europe (N = 503)	Latin America (N = 254)	Europe (N = 495)
Chronic/Widespread pain	86%*‡	78%	79%	78%	80%	79%
Problems sleeping	80%‡§	76%‡§	70%*	50%	69%*	55%
Fatigue	80%‡§	75%‡§	69%	67%	66%	69%
Headaches	69%‡§	77%*‡§	52%*	37%	45%	38%
Facial pain	59%‡§	69%*‡§	40%*†	24%	30%	27%
Heightened sensitivity to touch	61%‡§	72%*‡§	50%*	42%	48%	49%†
Difficulty concentrating	73%‡§	73%‡§	51%*	36%	50%*	39%
Numbness &/or tingling sensations	59%‡§	62%‡§	48%*†	25%	37%*	24%
Feelings of anxiety	75%*‡§	64%‡§	66%*	44%	64%*	47%
Feelings of depression	73%	77%‡§	74%*	58%	73%*	62%
Joint pain	80%‡§	76%‡§	68%*†	55%	54%	53%
Stiffness	74%‡§	74%‡§	59%*†	39%	44%	39%
Leg cramps	67%*‡§	60%‡§	42%*	24%	35%*	27%
Low back pain	81%*‡§	75%‡§	59%*†	44%	50%	45%

^a Base case: Physicians currently seeing or have seen patients with FM; * = P < 0.05 Europe vs. Latin America within group (Patient, PCP, Specialist); † P < 0.05 PCP vs. specialist (within region); ‡ P < 0.05 patient vs. PCP (within region); § P < 0.05 patient vs. specialist (within region).

ISSN: 1471-2474